<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01242644</url>
  </required_header>
  <id_info>
    <org_study_id>06-230</org_study_id>
    <nct_id>NCT01242644</nct_id>
  </id_info>
  <brief_title>Comparison of a Pain Pump Versus Injectable Medication for Analgesia in Knee Arthroscopy</brief_title>
  <official_title>Comparison of a Pain Pump Versus Injectable Medication for Analgesia in Knee Arthroscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of South Alabama</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of South Alabama</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypothesis: Ropivacaine, morphine and ketorolac injected after knee arthroscopy is as&#xD;
      effective as this solution plus ropivacaine administered intra-articularly for twenty-four&#xD;
      hours.&#xD;
&#xD;
      Three groups were assigned random patients, each group provided a different method of pain&#xD;
      medication in order to determine the effectiveness of each treatment.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Arthroscopic knee patients were randomized to 1 of 3 groups. A) 30mL of ropivacaine (0.5%),&#xD;
      30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100mL of&#xD;
      ropivacaine (0.5%) administered at 4 mL/hour; B) an identical solution plus a pain pump&#xD;
      containing 100-mL of normal saline administered at 4 mL/hour; C) an identical solution and no&#xD;
      pain pump. Pain level, the amount of pain medication used and time to discharge were&#xD;
      recorded. Clinical and radiographic evaluation was performed at nine months after surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2006</start_date>
  <completion_date type="Actual">June 2010</completion_date>
  <primary_completion_date type="Actual">October 2009</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Score 8 Hours Post-operativley</measure>
    <time_frame>8 hours post surgery</time_frame>
    <description>Visual Analog Scale. The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between &quot;no pain&quot; and &quot;worst pain. &quot;no pain&quot; on the left end (0 cm) of the scale and the &quot;worst pain&quot; on the right end of the scale (10 cm).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Scale</measure>
    <time_frame>24 hours post surgery</time_frame>
    <description>Visual Analog Scale. The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between &quot;no pain&quot; and &quot;worst pain. &quot;no pain&quot; on the left end (0 cm) of the scale and the &quot;worst pain&quot; on the right end of the scale (10 cm).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Scale</measure>
    <time_frame>48 hours post-surgery</time_frame>
    <description>Visual Analog Scale. The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between &quot;no pain&quot; and &quot;worst pain. &quot;no pain&quot; on the left end (0 cm) of the scale and the &quot;worst pain&quot; on the right end of the scale (10 cm).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Scale</measure>
    <time_frame>72 hours post surgery</time_frame>
    <description>Visual Analog Scale. The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between &quot;no pain&quot; and &quot;worst pain. &quot;no pain&quot; on the left end (0 cm) of the scale and the &quot;worst pain&quot; on the right end of the scale (10 cm).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Narcotic Pills and Morphine Sulfate Used</measure>
    <time_frame>In recovery room</time_frame>
    <description>Pill count</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Narcotic Pills and Morphine Sulfate Used</measure>
    <time_frame>Post surgery day 1</time_frame>
    <description>Pill Count</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Narcotic Pills and Morphine Sulfate Used</measure>
    <time_frame>Post surgery day 2</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Narcotic Pills and Morphine Sulfate Used</measure>
    <time_frame>Post surgery day 3</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">48</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>pain pump , injectable medication</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100mL of ropivacaine (0.5%) administered at 4 mL/hour;</description>
  </arm_group>
  <arm_group>
    <arm_group_label>saline pain pump , injectable medication</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100-mL of normal saline administered at 4 mL/hour</description>
  </arm_group>
  <arm_group>
    <arm_group_label>injectable medication only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected and no pain pump.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>pain pump containing ropivacaine</intervention_name>
    <description>30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100mL of ropivacaine (0.5%) administered at 4 mL/hour</description>
    <arm_group_label>pain pump , injectable medication</arm_group_label>
    <other_name>ropivacaine</other_name>
    <other_name>pain</other_name>
    <other_name>pump</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>saline pain pump with injectable medication</intervention_name>
    <description>30mL of ropivacaine(0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100-mL of normal saline administered at 4 mL/hour</description>
    <arm_group_label>saline pain pump , injectable medication</arm_group_label>
    <other_name>ketorolac</other_name>
    <other_name>saline</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ropivacaine, ketorolac , morphine sulfate</intervention_name>
    <description>30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected</description>
    <arm_group_label>injectable medication only</arm_group_label>
    <other_name>morphine</other_name>
    <other_name>sulfate</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: All subjects who underwent:&#xD;
&#xD;
          -  knee arthroscopy + synovectomy&#xD;
&#xD;
          -  knee arthroscopy + partial or complete meniscectomy&#xD;
&#xD;
          -  knee arthroscopy + chondroplasty&#xD;
&#xD;
          -  knee arthroscopy + microfracture&#xD;
&#xD;
          -  knee arthroscopy + autologous osteoarticular transplantation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  A surgical procedure that required an incision other then an arthroscopic portal&#xD;
&#xD;
          -  A surgical procedure within the same joint within ninety days&#xD;
&#xD;
          -  A acute or chronic knee infection&#xD;
&#xD;
          -  Any diagnosis of complex regional pain syndrome&#xD;
&#xD;
          -  A known allergy to one of the study drugs&#xD;
&#xD;
          -  A documented history of narcotic use&#xD;
&#xD;
          -  A score of less than two standard deviation on the SF-12 mental component&#xD;
&#xD;
          -  Any major systemic or cardiac illness (heart failure, uncontrolled angina,&#xD;
             bifascicular blocks, renal insufficiency, or liver disease)&#xD;
&#xD;
          -  Under the age of eighteen years&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Albert W Pearsall, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of South Alabama</affiliation>
  </overall_official>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 11, 2010</study_first_submitted>
  <study_first_submitted_qc>November 15, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 17, 2010</study_first_posted>
  <results_first_submitted>September 15, 2020</results_first_submitted>
  <results_first_submitted_qc>November 3, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">November 27, 2020</results_first_posted>
  <last_update_submitted>November 3, 2020</last_update_submitted>
  <last_update_submitted_qc>November 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketorolac</mesh_term>
    <mesh_term>Ketorolac Tromethamine</mesh_term>
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Pain Pump , Injectable Medication</title>
          <description>30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100mL of ropivacaine (0.5%) administered at 4 mL/hour;&#xD;
pain pump containing ropivacaine: 30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100mL of ropivacaine (0.5%) administered at 4 mL/hour</description>
        </group>
        <group group_id="P2">
          <title>Saline Pain Pump , Injectable Medication</title>
          <description>30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100-mL of normal saline administered at 4 mL/hour&#xD;
saline pain pump with injectable medication: 30mL of ropivacaine(0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100-mL of normal saline administered at 4 mL/hour</description>
        </group>
        <group group_id="P3">
          <title>Injectable Medication Only</title>
          <description>30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected and no pain pump.&#xD;
ropivacaine, ketorolac , morphine sulfate: 30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="17"/>
                <participants group_id="P3" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="17"/>
                <participants group_id="P3" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Pain Pump , Injectable Medication</title>
          <description>30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100mL of ropivacaine (0.5%) administered at 4 mL/hour;&#xD;
pain pump containing ropivacaine: 30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100mL of ropivacaine (0.5%) administered at 4 mL/hour</description>
        </group>
        <group group_id="B2">
          <title>Saline Pain Pump , Injectable Medication</title>
          <description>30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100-mL of normal saline administered at 4 mL/hour&#xD;
saline pain pump with injectable medication: 30mL of ropivacaine(0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100-mL of normal saline administered at 4 mL/hour</description>
        </group>
        <group group_id="B3">
          <title>Injectable Medication Only</title>
          <description>30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected and no pain pump.&#xD;
ropivacaine, ketorolac , morphine sulfate: 30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="16"/>
            <count group_id="B2" value="17"/>
            <count group_id="B3" value="15"/>
            <count group_id="B4" value="48"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                    <count group_id="B2" value="17"/>
                    <count group_id="B3" value="15"/>
                    <count group_id="B4" value="48"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51" spread="0.9"/>
                    <measurement group_id="B2" value="51" spread="0.9"/>
                    <measurement group_id="B3" value="49.9" spread="0.9"/>
                    <measurement group_id="B4" value="51" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex/Gender, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                    <count group_id="B2" value="17"/>
                    <count group_id="B3" value="15"/>
                    <count group_id="B4" value="48"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                    <count group_id="B2" value="17"/>
                    <count group_id="B3" value="15"/>
                    <count group_id="B4" value="48"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                    <count group_id="B4" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                    <count group_id="B2" value="17"/>
                    <count group_id="B3" value="15"/>
                    <count group_id="B4" value="48"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Pain Score 8 Hours Post-operativley</title>
        <description>Visual Analog Scale. The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between &quot;no pain&quot; and &quot;worst pain. &quot;no pain&quot; on the left end (0 cm) of the scale and the &quot;worst pain&quot; on the right end of the scale (10 cm).</description>
        <time_frame>8 hours post surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Pain Pump , Injectable Medication</title>
            <description>30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100mL of ropivacaine (0.5%) administered at 4 mL/hour;&#xD;
pain pump containing ropivacaine: 30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100mL of ropivacaine (0.5%) administered at 4 mL/hour</description>
          </group>
          <group group_id="O2">
            <title>Saline Pain Pump , Injectable Medication</title>
            <description>30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100-mL of normal saline administered at 4 mL/hour&#xD;
saline pain pump with injectable medication: 30mL of ropivacaine(0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100-mL of normal saline administered at 4 mL/hour</description>
          </group>
          <group group_id="O3">
            <title>Injectable Medication Only</title>
            <description>30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected and no pain pump.&#xD;
ropivacaine, ketorolac , morphine sulfate: 30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Score 8 Hours Post-operativley</title>
          <description>Visual Analog Scale. The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between &quot;no pain&quot; and &quot;worst pain. &quot;no pain&quot; on the left end (0 cm) of the scale and the &quot;worst pain&quot; on the right end of the scale (10 cm).</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="17"/>
                <count group_id="O3" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.5" spread="0.3282"/>
                    <measurement group_id="O2" value="1.8" spread="0.3282"/>
                    <measurement group_id="O3" value="1.06" spread="0.3282"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Pain Scale</title>
        <description>Visual Analog Scale. The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between &quot;no pain&quot; and &quot;worst pain. &quot;no pain&quot; on the left end (0 cm) of the scale and the &quot;worst pain&quot; on the right end of the scale (10 cm).</description>
        <time_frame>24 hours post surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Pain Pump , Injectable Medication</title>
            <description>30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100mL of ropivacaine (0.5%) administered at 4 mL/hour;&#xD;
pain pump containing ropivacaine: 30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100mL of ropivacaine (0.5%) administered at 4 mL/hour</description>
          </group>
          <group group_id="O2">
            <title>Saline Pain Pump , Injectable Medication</title>
            <description>30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100-mL of normal saline administered at 4 mL/hour&#xD;
saline pain pump with injectable medication: 30mL of ropivacaine(0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100-mL of normal saline administered at 4 mL/hour</description>
          </group>
          <group group_id="O3">
            <title>Injectable Medication Only</title>
            <description>30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected and no pain pump.&#xD;
ropivacaine, ketorolac , morphine sulfate: 30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Scale</title>
          <description>Visual Analog Scale. The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between &quot;no pain&quot; and &quot;worst pain. &quot;no pain&quot; on the left end (0 cm) of the scale and the &quot;worst pain&quot; on the right end of the scale (10 cm).</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="17"/>
                <count group_id="O3" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.75" spread="0.16"/>
                    <measurement group_id="O2" value="3.23" spread="0.16"/>
                    <measurement group_id="O3" value="3.06" spread="0.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Pain Scale</title>
        <description>Visual Analog Scale. The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between &quot;no pain&quot; and &quot;worst pain. &quot;no pain&quot; on the left end (0 cm) of the scale and the &quot;worst pain&quot; on the right end of the scale (10 cm).</description>
        <time_frame>48 hours post-surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Pain Pump , Injectable Medication</title>
            <description>30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100mL of ropivacaine (0.5%) administered at 4 mL/hour;&#xD;
pain pump containing ropivacaine: 30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100mL of ropivacaine (0.5%) administered at 4 mL/hour</description>
          </group>
          <group group_id="O2">
            <title>Saline Pain Pump , Injectable Medication</title>
            <description>30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100-mL of normal saline administered at 4 mL/hour&#xD;
saline pain pump with injectable medication: 30mL of ropivacaine(0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100-mL of normal saline administered at 4 mL/hour</description>
          </group>
          <group group_id="O3">
            <title>Injectable Medication Only</title>
            <description>30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected and no pain pump.&#xD;
ropivacaine, ketorolac , morphine sulfate: 30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Scale</title>
          <description>Visual Analog Scale. The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between &quot;no pain&quot; and &quot;worst pain. &quot;no pain&quot; on the left end (0 cm) of the scale and the &quot;worst pain&quot; on the right end of the scale (10 cm).</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="17"/>
                <count group_id="O3" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.81" spread="0.14"/>
                    <measurement group_id="O2" value="3.17" spread="0.14"/>
                    <measurement group_id="O3" value="2.26" spread="0.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Pain Scale</title>
        <description>Visual Analog Scale. The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between &quot;no pain&quot; and &quot;worst pain. &quot;no pain&quot; on the left end (0 cm) of the scale and the &quot;worst pain&quot; on the right end of the scale (10 cm).</description>
        <time_frame>72 hours post surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Pain Pump , Injectable Medication</title>
            <description>30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100mL of ropivacaine (0.5%) administered at 4 mL/hour;&#xD;
pain pump containing ropivacaine: 30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100mL of ropivacaine (0.5%) administered at 4 mL/hour</description>
          </group>
          <group group_id="O2">
            <title>Saline Pain Pump , Injectable Medication</title>
            <description>30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100-mL of normal saline administered at 4 mL/hour&#xD;
saline pain pump with injectable medication: 30mL of ropivacaine(0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100-mL of normal saline administered at 4 mL/hour</description>
          </group>
          <group group_id="O3">
            <title>Injectable Medication Only</title>
            <description>30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected and no pain pump.&#xD;
ropivacaine, ketorolac , morphine sulfate: 30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Scale</title>
          <description>Visual Analog Scale. The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between &quot;no pain&quot; and &quot;worst pain. &quot;no pain&quot; on the left end (0 cm) of the scale and the &quot;worst pain&quot; on the right end of the scale (10 cm).</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="17"/>
                <count group_id="O3" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.3" spread="0.46"/>
                    <measurement group_id="O2" value="4.05" spread="0.46"/>
                    <measurement group_id="O3" value="3.13" spread="0.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Narcotic Pills and Morphine Sulfate Used</title>
        <description>Pill count</description>
        <time_frame>In recovery room</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Pain Pump , Injectable Medication</title>
            <description>30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100mL of ropivacaine (0.5%) administered at 4 mL/hour;&#xD;
pain pump containing ropivacaine: 30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100mL of ropivacaine (0.5%) administered at 4 mL/hour</description>
          </group>
          <group group_id="O2">
            <title>Saline Pain Pump , Injectable Medication</title>
            <description>30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100-mL of normal saline administered at 4 mL/hour&#xD;
saline pain pump with injectable medication: 30mL of ropivacaine(0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100-mL of normal saline administered at 4 mL/hour</description>
          </group>
          <group group_id="O3">
            <title>Injectable Medication Only</title>
            <description>30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected and no pain pump.&#xD;
ropivacaine, ketorolac , morphine sulfate: 30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Narcotic Pills and Morphine Sulfate Used</title>
          <description>Pill count</description>
          <units>Pills</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="17"/>
                <count group_id="O3" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.2" spread="0.61"/>
                    <measurement group_id="O2" value="1.8" spread="0.61"/>
                    <measurement group_id="O3" value="1.3" spread="0.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Narcotic Pills and Morphine Sulfate Used</title>
        <description>Pill Count</description>
        <time_frame>Post surgery day 1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Pain Pump , Injectable Medication</title>
            <description>30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100mL of ropivacaine (0.5%) administered at 4 mL/hour;&#xD;
pain pump containing ropivacaine: 30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100mL of ropivacaine (0.5%) administered at 4 mL/hour</description>
          </group>
          <group group_id="O2">
            <title>Saline Pain Pump , Injectable Medication</title>
            <description>30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100-mL of normal saline administered at 4 mL/hour&#xD;
saline pain pump with injectable medication: 30mL of ropivacaine(0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100-mL of normal saline administered at 4 mL/hour</description>
          </group>
          <group group_id="O3">
            <title>Injectable Medication Only</title>
            <description>30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected and no pain pump.&#xD;
ropivacaine, ketorolac , morphine sulfate: 30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Narcotic Pills and Morphine Sulfate Used</title>
          <description>Pill Count</description>
          <units>Number of pills</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="17"/>
                <count group_id="O3" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.41" spread="0.87"/>
                    <measurement group_id="O2" value="3.8" spread="0.87"/>
                    <measurement group_id="O3" value="3.8" spread="0.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Narcotic Pills and Morphine Sulfate Used</title>
        <time_frame>Post surgery day 2</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Pain Pump , Injectable Medication</title>
            <description>30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100mL of ropivacaine (0.5%) administered at 4 mL/hour;&#xD;
pain pump containing ropivacaine: 30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100mL of ropivacaine (0.5%) administered at 4 mL/hour</description>
          </group>
          <group group_id="O2">
            <title>Saline Pain Pump , Injectable Medication</title>
            <description>30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100-mL of normal saline administered at 4 mL/hour&#xD;
saline pain pump with injectable medication: 30mL of ropivacaine(0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100-mL of normal saline administered at 4 mL/hour</description>
          </group>
          <group group_id="O3">
            <title>Injectable Medication Only</title>
            <description>30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected and no pain pump.&#xD;
ropivacaine, ketorolac , morphine sulfate: 30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Narcotic Pills and Morphine Sulfate Used</title>
          <units>Number of pills</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="17"/>
                <count group_id="O3" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.1" spread="0.08"/>
                    <measurement group_id="O2" value="1.5" spread="0.08"/>
                    <measurement group_id="O3" value="0.8" spread="0.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Narcotic Pills and Morphine Sulfate Used</title>
        <time_frame>Post surgery day 3</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Pain Pump , Injectable Medication</title>
            <description>30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100mL of ropivacaine (0.5%) administered at 4 mL/hour;&#xD;
pain pump containing ropivacaine: 30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100mL of ropivacaine (0.5%) administered at 4 mL/hour</description>
          </group>
          <group group_id="O2">
            <title>Saline Pain Pump , Injectable Medication</title>
            <description>30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100-mL of normal saline administered at 4 mL/hour&#xD;
saline pain pump with injectable medication: 30mL of ropivacaine(0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100-mL of normal saline administered at 4 mL/hour</description>
          </group>
          <group group_id="O3">
            <title>Injectable Medication Only</title>
            <description>30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected and no pain pump.&#xD;
ropivacaine, ketorolac , morphine sulfate: 30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Narcotic Pills and Morphine Sulfate Used</title>
          <units>number of pills</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="17"/>
                <count group_id="O3" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1" spread="0.16"/>
                    <measurement group_id="O2" value="2.7" spread="0.16"/>
                    <measurement group_id="O3" value="1.7" spread="0.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>At 12 months post-operatively</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Pain Pump , Injectable Medication</title>
          <description>30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100mL of ropivacaine (0.5%) administered at 4 mL/hour;&#xD;
pain pump containing ropivacaine: 30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100mL of ropivacaine (0.5%) administered at 4 mL/hour</description>
        </group>
        <group group_id="E2">
          <title>Saline Pain Pump , Injectable Medication</title>
          <description>30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100-mL of normal saline administered at 4 mL/hour&#xD;
saline pain pump with injectable medication: 30mL of ropivacaine(0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100-mL of normal saline administered at 4 mL/hour</description>
        </group>
        <group group_id="E3">
          <title>Injectable Medication Only</title>
          <description>30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected and no pain pump.&#xD;
ropivacaine, ketorolac , morphine sulfate: 30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Office of Research Compliance</name_or_title>
      <organization>University of South Alabama</organization>
      <phone>251-460-7573</phone>
      <email>swhite@southalabama.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

